232 related articles for article (PubMed ID: 11080163)
1. Vav-2 controls NFAT-dependent transcription in B- but not T-lymphocytes.
Doody GM; Billadeau DD; Clayton E; Hutchings A; Berland R; McAdam S; Leibson PJ; Turner M
EMBO J; 2000 Nov; 19(22):6173-84. PubMed ID: 11080163
[TBL] [Abstract][Full Text] [Related]
2. Vav-Rac1-mediated activation of the c-Jun N-terminal kinase/c-Jun/AP-1 pathway plays a major role in stimulation of the distal NFAT site in the interleukin-2 gene promoter.
Kaminuma O; Deckert M; Elly C; Liu YC; Altman A
Mol Cell Biol; 2001 May; 21(9):3126-36. PubMed ID: 11287617
[TBL] [Abstract][Full Text] [Related]
3. The adaptor protein 3BP2 associates with VAV guanine nucleotide exchange factors to regulate NFAT activation by the B-cell antigen receptor.
Foucault I; Le Bras S; Charvet C; Moon C; Altman A; Deckert M
Blood; 2005 Feb; 105(3):1106-13. PubMed ID: 15345594
[TBL] [Abstract][Full Text] [Related]
4. RhoG regulates gene expression and the actin cytoskeleton in lymphocytes.
Vigorito E; Billadeu DD; Savoy D; McAdam S; Doody G; Fort P; Turner M
Oncogene; 2003 Jan; 22(3):330-42. PubMed ID: 12545154
[TBL] [Abstract][Full Text] [Related]
5. A Nck-Pak1 signaling module is required for T-cell receptor-mediated activation of NFAT, but not of JNK.
Yablonski D; Kane LP; Qian D; Weiss A
EMBO J; 1998 Oct; 17(19):5647-57. PubMed ID: 9755165
[TBL] [Abstract][Full Text] [Related]
6. Vav modulation of the Ras/MEK/ERK signaling pathway plays a role in NFAT activation and CD69 up-regulation.
Villalba M; Hernandez J; Deckert M; Tanaka Y; Altman A
Eur J Immunol; 2000 Jun; 30(6):1587-96. PubMed ID: 10898494
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine phosphorylation of adaptor protein 3BP2 induces T cell receptor-mediated activation of transcription factor.
Qu X; Kawauchi-Kamata K; Miah SM; Hatani T; Yamamura H; Sada K
Biochemistry; 2005 Mar; 44(10):3891-8. PubMed ID: 15751964
[TBL] [Abstract][Full Text] [Related]
8. The Rho family guanine nucleotide exchange factor Vav-2 regulates the development of cell-mediated cytotoxicity.
Billadeau DD; Mackie SM; Schoon RA; Leibson PJ
J Exp Med; 2000 Aug; 192(3):381-92. PubMed ID: 10934226
[TBL] [Abstract][Full Text] [Related]
9. Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product.
Deckert M; Tartare-Deckert S; Couture C; Mustelin T; Altman A
Immunity; 1996 Dec; 5(6):591-604. PubMed ID: 8986718
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs.
Margolis B; Hu P; Katzav S; Li W; Oliver JM; Ullrich A; Weiss A; Schlessinger J
Nature; 1992 Mar; 356(6364):71-4. PubMed ID: 1531699
[TBL] [Abstract][Full Text] [Related]
11. Specific subdomains of Vav differentially affect T cell and NK cell activation.
Billadeau DD; Mackie SM; Schoon RA; Leibson PJ
J Immunol; 2000 Apr; 164(8):3971-81. PubMed ID: 10754287
[TBL] [Abstract][Full Text] [Related]
12. Vav2 activates c-fos serum response element and CD69 expression but negatively regulates nuclear factor of activated T cells and interleukin-2 gene activation in T lymphocyte.
Tartare-Deckert S; Monthouel MN; Charvet C; Foucault I; Van Obberghen E; Bernard A; Altman A; Deckert M
J Biol Chem; 2001 Jun; 276(24):20849-57. PubMed ID: 11262396
[TBL] [Abstract][Full Text] [Related]
13. An NFAT-dependent enhancer is necessary for anti-IgM-mediated induction of murine CD5 expression in primary splenic B cells.
Berland R; Wortis HH
J Immunol; 1998 Jul; 161(1):277-85. PubMed ID: 9647234
[TBL] [Abstract][Full Text] [Related]
14. Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells.
Fujikawa K; Miletic AV; Alt FW; Faccio R; Brown T; Hoog J; Fredericks J; Nishi S; Mildiner S; Moores SL; Brugge J; Rosen FS; Swat W
J Exp Med; 2003 Nov; 198(10):1595-608. PubMed ID: 14623913
[TBL] [Abstract][Full Text] [Related]
15. Vav family proteins couple to diverse cell surface receptors.
Moores SL; Selfors LM; Fredericks J; Breit T; Fujikawa K; Alt FW; Brugge JS; Swat W
Mol Cell Biol; 2000 Sep; 20(17):6364-73. PubMed ID: 10938113
[TBL] [Abstract][Full Text] [Related]
16. Differential phosphorylation of functional tyrosines in CD19 modulates B-lymphocyte activation.
Ishiura N; Nakashima H; Watanabe R; Kuwano Y; Adachi T; Takahashi Y; Tsubata T; Okochi H; Tamaki K; Tedder TF; Fujimoto M
Eur J Immunol; 2010 Apr; 40(4):1192-204. PubMed ID: 20101619
[TBL] [Abstract][Full Text] [Related]
17. A functional T-cell receptor signaling pathway is required for p95vav activity.
Wu J; Katzav S; Weiss A
Mol Cell Biol; 1995 Aug; 15(8):4337-46. PubMed ID: 7623828
[TBL] [Abstract][Full Text] [Related]
18. hSiah2 is a new Vav binding protein which inhibits Vav-mediated signaling pathways.
Germani A; Romero F; Houlard M; Camonis J; Gisselbrecht S; Fischer S; Varin-Blank N
Mol Cell Biol; 1999 May; 19(5):3798-807. PubMed ID: 10207103
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of NFAT and SRF by the B cell receptor via a PLCgamma-Ca(2+)-dependent pathway.
Hao S; Kurosaki T; August A
EMBO J; 2003 Aug; 22(16):4166-77. PubMed ID: 12912915
[TBL] [Abstract][Full Text] [Related]
20. CD28 utilizes Vav-1 to enhance TCR-proximal signaling and NF-AT activation.
Michel F; Mangino G; Attal-Bonnefoy G; Tuosto L; Alcover A; Roumier A; Olive D; Acuto O
J Immunol; 2000 Oct; 165(7):3820-9. PubMed ID: 11034388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
